John Parkinson is the assistant managing editor for Contagion. Prior to joining MJH Life Sciences in 2020, he has covered a variety of fields and markets including diabetes, oncology, ophthalmology, IT, travel, and local news. You can email him at jparkinson@mjhlifesciences.com.
Moderna’s Influenza-COVID-19 Combination Vaccine Elicits Immune Response in Older Adults
June 10th 2024The company announced data this morning for its investigational mRNA-1083 vaccine and plans to continue collecting data and working towards submitting a Biological License Application (BLA) for it.
Read More
Top Infectious Disease News Stories Week of June 1-7
June 7th 2024FDA VRBPAC recommends protection against JN1 for the fall COVID-19 vaccines, a multidrug-resistant form of gonorrhea gives cause for concern, piperacillin-tazobactam shown to have higher mortality than cefepime for sepsis, and more this week from Contagion.
Read More
750,000 Global Deaths Linked to AMR Could be Prevented Annually
May 28th 2024A new series reviewing antimicrobial resistance (AMR) reduction strategies shows that available vaccines, water and sanitation, and infection control methods could greatly reduce the mortality associated with this major health crisis.
Read More
The Means for Curative Hepatitis C Care are Available, But Many Still Don’t Utilize
May 22nd 2024A newer strategic approach combined with existing treatments are together trying to reduce incidence rates and cure people of HCV, but barriers to treatment remain, and often leave people outside the continuum of care.
Read More
Mortality is 35% Higher for COVID-19 Hospitalized Patients Compared to Influenza Inpatients
May 16th 2024A new study demonstrates that for last year’s respiratory season, the difference in death rates were still much higher for COVID-19, but the gap closed significantly from the year before.
Read More
Living With C diff: Witnessing and Participating in an Evolution of Awareness, Medical Care
May 15th 2024Dennis Petragnani has battled gastrointestinal issues for years, and he shares what he sees as the transformation of change in the public and medical community talking about C diff and therapies around it, and the kinship with people he has met through the Peggy Lillis Foundation.
Read More